The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

suzetrigine is thought to be nonaddictive because it targets nerve cells outside the brain. “A novel, effective pain medication that has no potential to induce overdose or addiction is a game ...